The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC)

The principal strategy adopted by the African Programme for Onchocerciasis Control (APOC), for the control of onchocerciasis in the 19 countries of Africa that now fall within the programme's remit, is that of community-directed treatment with ivermectin (CDTI). Halfway through its 12-year mandate, APOC has gathered enough information on the main challenges to guide its activities in Phase 2. An analysis of reports and other documents, emanating from consultants, scientists, monitors and national and project-level implementers, indicates that there are three broad categories of challenge: managerial; technical; and socio-political. Under these three categories, this review identifies the most pertinent concerns that APOC must address, during Phase 2, to enhance the prospects of establishing sustainable systems for ivermectin distribution. The major challenges include: (1) maintaining timely drug-collection mechanisms; (2) integrating CDTI with existing primary-healthcare services; (3) strengthening local health infrastructure; (4) achieving and maintaining an optimal treatment coverage; (5) establishing and up-scaling community self-monitoring; (6) designing and implementing operations research locally; (7) ensuring the adequacy of community-directed distributors; (8) increasing the involvement of local non-govemmental develop organizations in the programme; (9) achieving financial sustainability; (10) implementing equitable cost-recovery systems; and (11) engaging in effective advocacy. The implications of the challenges and suggestions about how they are being (or could be) addressed are also highlighted in this brief review, which should be of value to other programmes and agencies that may be contemplating the adoption of this unique strategy.

Public health interventions, barriers, and opportunities for improving maternal nutrition in Northeast Nigeria

BACKGROUND

Efficacious strategies to improve maternal nutrition and subsequent maternal, neonatal, and child health exist, but their utilization and application at scale is limited.

OBJECTIVE

This study explored the gaps, barriers, and opportunities for maternal nutrition policy and programming in Nigeria, a country with a disproportionate share of the global burden of maternal and child mortality

METHODS

Research was conducted in three phases in four Local Government Authorities in Taraba State. Phase 1 consisted of a desk review of policies, programs, and sociodemographic and health indicators pertinent to maternal nutrition. In-depth interviews were conducted with key informants in state and local ministries of health as well as international nongovernmental organizations and community- and faith-based organizations. Phase 2 utilized in-depth interviews and focus group discussions with community leaders, health promoters, and mothers. Phase 3 consisted of key informant interviews with federal policy and program leaders in government ministries and nongovernmental organizations.

RESULTS

Nutrition, especially maternal nutrition, is not prioritized and is poorly funded in both the governmental and the nongovernmental systems. Perceived weak advocacy for nutrition and its role in economic development and the lack of coordination among governmental and nongovernmental actors were said to contribute to low prioritization. Dependence on health facilities as the primary platform for delivering maternal nutrition is problematic, given severe resource constraints and perceived community barriers, including cost, distance, and poor quality of care.

CONCLUSIONS

Advocacy for maternal nutrition that improves understanding of its consequences for health and economic development could hasten prioritization, coordination, and investment in maternal nutrition at the national, state, and local levels. Innovative, multisectoral strategies that move beyond facility-based platforms are needed to reduce the burden of maternal undernutrition in Northeast Nigeria.

Robotic health assistant (Feverkit) for the rational management of fevers among nomads in Nigeria

The innovation described in this paper was motivated by concern that in Africa, parasite resistance to antimalarial drugs is associated with irrational drug use where health facilities are inaccessible. However, advancement in digital technology, simple diagnostic devices and smart drug packaging inspire innovative strategies. The combination of communication technology, rapid diagnostic tools, and antibiotic and antimalarial medicines can increase access to evidence-based malaria management, reduce mortality and slow the development of resistance to drugs. The author initiated development of a solar-powered device (Feverkit) programmed with user-interactive capabilities and equipped with a detachable laboratory and dispensary for community management of fevers. The operational performance of 10 units of the device was evaluated among 20 nomadic Fulani communities in northeastern Nigeria. A brief introduction to its parts and functions was sufficient for community-selected nomadic caregivers to use it competently for managing 207 fever cases in eight weeks, with a 97% (p=.000) recovery rate. The Feverkit guided the nomads to distinguish between malaria and non-malaria-induced fevers, and thus selectively treat them. Camp communities accepted the device and were willing to pay between US$33 and $334 (mean, $113; mode, $67) to keep it. Public-private sector collaboration is essential for sustaining and scaling up production of the Feverkit as a commercial health device for the management of fevers among nomads.